Inder Verma | |
---|---|
Born | Inder Mohan Verma 28 November 1947 Sangrur, Punjab, India |
Alma mater | Lucknow University Massachusetts Institute of Technology Weizmann Institute of Science |
Known for | Cancer, gene therapy, NF-kB |
Awards | Member of the National Academy of Sciences (1997) [1] EMBO Member (1998) [2] |
Scientific career | |
Fields | Molecular Biology |
Institutions | Salk Institute for Biological Studies |
Academic advisors | David Baltimore |
Inder Mohan Verma (born 28 November 1947) is an Indian American molecular biologist, the former Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies [3] and the University of California, San Diego. [4] [5] He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.
Verma was the editor-in-chief of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) from 2011 to 2018, [6] but stepped down after being named in a gender discrimination lawsuit against the Salk Institute. [7] In April 2018 the Salk institute placed him on leave for "unspecified allegations"; Verma himself stated that the leave was connected to the same lawsuit, [8] but it came shortly before publication of an exposé alleging decades-long sexual harassment and assault of multiple women by Verma. In June 2018 he resigned his position at the Salk Institute, before the board of trustees of the institute could take action regarding these allegations. [9]
Inder M. Verma was born in 1947 in Sangrur, Punjab, India and educated at Lucknow University. He received his Ph.D. from the Weizmann Institute of Science in Israel in 1971.
After his PhD, Verma conducted his postdoctoral research in the laboratory of Nobel laureate David Baltimore at MIT. In 1974, Verma joined the Salk Institute as an assistant professor. He was promoted to associate professor in 1979, and professor in 1985. He also holds an adjunct professor appointment at the University of California, San Diego. Among his professional activities, he is a member of the Board of Scientific Governors of The Scripps Research Institute. He is currently[ when? ] at the center of a lawsuit alleging systematic discrimination against women scientists at the Salk Institute. [10]
Verma is a recognized leader in gene therapy, retrovirology, and cancer. His work on viruses and cancer led to the identification of several oncogenes,[ citation needed ] including c-fos, and their function in normal cells. His development of virus mediated gene transfer techniques, including a stripped down version of HIV, has become the foundation for gene therapy to cure several congenital as well as adult onset diseases including cancer. The viral vectors are routinely used in molecular biology laboratories.
He married Grietje van der Woude in 1973. They have a daughter Simone, who lives in La Jolla. They have twin granddaughters, Sophie and Marijke.
In April 2018, Science published accounts by eight women who accused Verma of sexual harassment from 1976 to 2016. On 20 April 2018 Salk’s board of trustees put Verma on administrative leave, two days after receiving a list of questions from Science concerning the allegations and the institute’s responses to previous complaints about Verma’s behavior. [16] The American Association for the Advancement of Science removed his Fellow title after the allegations were confirmed. [17] [18]
Francisco José Ayala Pereda was a Spanish-American evolutionary biologist and philosopher who was a longtime faculty member at the University of California, Irvine, and University of California, Davis.
Fellowship of the American Association for the Advancement of Science (FAAAS) is an honor accorded by the American Association for the Advancement of Science (AAAS) to distinguished persons who are members of the Association. Fellows are elected annually by the AAAS Council for "efforts on behalf of the advancement of science or its applications [which] are scientifically or socially distinguished".
Gerald Francis "Jerry" Joyce is president and professor at the Salk Institute for Biological Studies and was previously the director of the Genomics Institute of the Novartis Research Foundation. He is best known for his work on in vitro evolution, for the discovery of the first DNA enzyme (deoxyribozyme), for his work in discovering potential RNA world ribozymes, and more in general for his work on the origin of life.
John Kuriyan is the dean of basic sciences and a professor of biochemistry at Vanderbilt University School of Medicine. He was formerly the Chancellor's Professor at the University of California, Berkeley in the departments of molecular and cell biology (MCB) and chemistry, a faculty scientist in Berkeley Lab's physical biosciences division, and a Howard Hughes Medical Institute investigator. He is a member of the National Academy of Sciences and he has also been on the Life Sciences jury for the Infosys Prize in 2009, 2019 and 2020.
Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.
Nenad Ban is a biochemist born in Zagreb, Croatia who currently works at the ETH Zurich, Swiss Federal Institute of Technology, as a professor of Structural Molecular Biology. He is a pioneer in studying gene expression mechanisms and the participating protein synthesis machinery.
David M. Sabatini is an American scientist and a former professor of biology at the Massachusetts Institute of Technology. From 2002 to 2021, he was a member of the Whitehead Institute for Biomedical Research. He was also an investigator of the Howard Hughes Medical Institute from 2008 to 2021 and was elected to the National Academy of Sciences in 2016. He is known for his contributions in the areas of cell signaling and cancer metabolism, most notably the co-discovery of mTOR.
Joanne Chory is an American plant biologist and geneticist. Chory is a professor and director of the Plant Molecular and Cellular Biology Laboratory, at the Salk Institute for Biological Studies and an investigator of the Howard Hughes Medical Institute.
Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".
Kathleen Kay Treseder is an American ecologist who specializes in the interplay between global climate change and fungal ecology. She also serves as a member of the Irvine City Council after being elected to the position in 2022. She is currently a professor in the Department of Ecology and Evolutionary Biology at the University of California, Irvine. She is a Fellow of the American Association for the Advancement of Science, the American Academy of Microbiology, and the Ecological Society of America.
Galit Lahav is an Israeli-American systems biologist and Professor of Systems Biology at Harvard Medical School. In 2018 she became Chair of the Department of Systems Biology at Harvard Medical School. She is known for discovering the pulsatile behavior of the tumor suppressor protein p53 and uncovering its significance for cell fate, and for her contributions to the culture of mentoring in science. She lives in Boston, Massachusetts.
Ibrahim I. Cissé is a Nigerien-American biophysicist. He is currently director of the Max Planck Institute of Immunobiology and Epigenetics. Previously, Cissé was at the California Institute of Technology as Professor of Physics and the Massachusetts Institute of Technology as Professor of Physics and Biology. He has won several awards for his work, including in 2021 the MacArthur Fellowship.
Beverly M. Emerson is an Emeritus Professor of Biological Sciences at the Salk Institute for Biological Studies who uncovered details about how cancer becomes drug resistant. She is currently at the Oregon Health & Science University’s Knight Cancer Institute. She is a Fellow of the American Association for the Advancement of Science.
Clodagh C. O'Shea is a professor of molecular and cell biology and current Wicklow Chair at the Salk Institute for Biological Sciences and a scholar at the Howard Hughes Medical Institute. She is also an adjunct professor at UCSD and the Scientific Founder of IconOVir Bio.
Paolo Sassone-Corsi was an Italian molecular biologist, epigeneticist, and researcher. He is known for his contributions in the areas of transcriptional regulation, epigenetics, circadian biology, and metabolic regulation. He is known for his contributions in the areas of transcriptional regulation, epigenetics, circadian biology, and metabolic regulation. His research primarily focused on the mechanisms that regulate transcription and their relation to metabolism and circadian clocks. His work focused on understanding how the circadian clock regulates metabolic cycles. Most notably, he discovered that SIRT1, a histone deacetylase with a critical role in gene expression and metabolism, is able to regulate the activity of the CLOCK protein. In 2011, Sassone-Corsi founded and directed the “Center for Epigenetics and Metabolism” at the University of California, Irvine.
Didier Trono is a Swiss virologist and a professor at the École Polytechnique Fédérale de Lausanne (EPFL). He is known for his research on virus-host interactions and the development of lentiviral vectors for gene therapy.
Maria Grazia Roncarolo is an Italian pediatrician who is currently George D. Smith Professor in Stem Cell and Regenerative Medicine and Professor of Medicine at Stanford University. She is also the Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine along with Irving Weissman and Michael Longaker and the Director for Center for Definitive and Curative Medicine at Stanford.
Yardena Samuels or Samuels-Lev is an Israeli molecular biologist who is the Director of the Ekard Institute for Cancer Diagnosis Research at the Weizmann Institute of Science. Her research considers the genetic mutations of melanoma.
Luigi Naldini is an Italian gene therapist, professor of cell and tissue biology and of gene and cell therapy at Vita-Salute San Raffaele University, and the director of San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Often considered as "the father of the lentivirus gene therapy", he is globally known as the pioneer of "the development and applications of lentiviral vectors for gene transfer" that allowed the gene therapy treatment of several genetic diseases. He is also a scientific co-founder of three biotech start-up companies, Genenta in Milan and New York, Chroma Medicine in Milan and Boston, Genespire in Milan. He is also the former president of European Society of Gene and Cell Therapy (ESGCT) and an elected member of European Molecular Biology Organization (EMBO). In 2019, he was awarded Louis-Jeantet Prize for Medicine "for taking gene therapy from the bench to the bedside".
Harmit Singh Malik is an Indian American evolutionary biologist who is a professor and associate director at the Fred Hutchinson Cancer Research Center. He was awarded the 2022 Genetics Society of America Edward Novitski Prize.